PEAK6 Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-15,700
Closed -$839K 4672
2017
Q4
$839K Sell
15,700
-22,200
-59% -$1.05M ﹤0.01% 2057
2017
Q3
$1.63M Buy
37,900
+7,400
+24% +$352K 0.01% 1553
2017
Q2
$1.84M Buy
+30,500
New +$1.81M 0.01% 1416
2017
Q1
Sell
-1,000
Closed -$67K 4701
2016
Q4
$67K Sell
1,000
-12,500
-93% -$813K ﹤0.01% 4077
2016
Q3
$894K Buy
13,500
+7,100
+111% +$486K 0.01% 1864
2016
Q2
$464K Sell
6,400
-2,000
-24% -$137K ﹤0.01% 2426
2016
Q1
$543K Buy
8,400
+3,300
+65% +$219K ﹤0.01% 2204
2015
Q4
$365K Hold
5,100
﹤0.01% 2908
2015
Q3
$392K Buy
+5,100
New +$412K ﹤0.01% 3106
2015
Q2
Sell
-6,900
Closed -$500K 5285
2015
Q1
$500K Buy
+6,900
New +$480K ﹤0.01% 2534
2014
Q3
Sell
-800
Closed -$47K 4961
2014
Q2
$47K Sell
800
-27,600
-97% -$1.62M ﹤0.01% 4082
2014
Q1
$1.76M Buy
+28,400
New +$1.65M 0.02% 1372
2013
Q4
Sell
-9,200
Closed -$231K 5198
2013
Q3
$231K Sell
9,200
-220,000
-96% -$10.7M ﹤0.01% 3560
2013
Q2
$10.5K Buy
+229,200
New +$10.3M 0.04% 299

Other funds holding MD

PEAK6 Group's MD Position: Q2 2018 in Review

PEAK6 Group reduced its Pediatrix Medical (MD) stake by 64% in Q2 2018, selling an estimated $528K and leaving 6,259 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #3108.

PEAK6 Group first reported a position in MD in Q2 2013 and has held it in 11 quarters since. The position peaked at $2.11M in Q3 2013. 322 funds tracked by Wall St. Rank hold MD as of Q2 2018.

  • PEAK6 Group held 6,259 shares of Pediatrix Medical worth $271K as of Q2 2018.
  • PEAK6 Group sold 11,011 Pediatrix Medical shares in Q2 2018, an estimated $528K.
  • Pediatrix Medical made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3108 holding.
  • PEAK6 Group first reported a position in Pediatrix Medical in Q2 2013 and has held it in 11 quarters since.
  • PEAK6 Group's Pediatrix Medical position peaked at $2.11M in Q3 2013.
  • 322 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.